Cargando…
Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera
BACKGROUND: Investigating the neutralizing antibody (NAb) titer against HSV-1 is essential for monitoring the immune protection against HSV-1 in susceptible populations, which would facilitate the development of vaccines against herpes infection and improvement of HSV-1 based oncolytic virotherapy....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797254/ https://www.ncbi.nlm.nih.gov/pubmed/26987753 http://dx.doi.org/10.1186/s12985-016-0508-4 |
_version_ | 1782421920538427392 |
---|---|
author | Luo, Yong Xiong, Dan Li, Huan-Huan Qiu, Sheng-Ping Lin, Chao-Long Chen, Qin Huang, Cheng-Hao Yuan, Quan Zhang, Jun Xia, Ning-Shao |
author_facet | Luo, Yong Xiong, Dan Li, Huan-Huan Qiu, Sheng-Ping Lin, Chao-Long Chen, Qin Huang, Cheng-Hao Yuan, Quan Zhang, Jun Xia, Ning-Shao |
author_sort | Luo, Yong |
collection | PubMed |
description | BACKGROUND: Investigating the neutralizing antibody (NAb) titer against HSV-1 is essential for monitoring the immune protection against HSV-1 in susceptible populations, which would facilitate the development of vaccines against herpes infection and improvement of HSV-1 based oncolytic virotherapy. RESULTS: In this study, we have developed a neutralization test based on the enzyme-linked immunospot assay (ELISPOT-NT) to determine the neutralizing antibody titer against HSV-1 in human serum samples. This optimized assay employed a monoclonal antibody specifically recognizing glycoprotein D to detect the HSV-1 infected cells. With this test, the neutralizing antibody titer against HSV-1 could be determined within one day by automated interpretation of the counts of cell spots. We observed good correlation in the results obtained from ELISPOT-NT and plaque reduction neutralization test (PRNT) by testing 22 human serum samples representing different titers. Moreover, 269 human serum samples collected from a wide range of age groups were tested, the average neutralizing antibody titer (log(2)NT(50)) was 8.3 ± 2.8 and the prevalence of NAbs was 83.6 % in this cohort, it also revealed that the average neutralizing antibody titer in different groups increased with the age, and no significant difference in neutralizing antibody titers was observed between males and females. CONCLUSIONS: These results prove that this novel assay would serve as an accurate and simple assay for the assessment of the neutralizing antibody titers against HSV-1 in large cohorts. |
format | Online Article Text |
id | pubmed-4797254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47972542016-03-19 Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera Luo, Yong Xiong, Dan Li, Huan-Huan Qiu, Sheng-Ping Lin, Chao-Long Chen, Qin Huang, Cheng-Hao Yuan, Quan Zhang, Jun Xia, Ning-Shao Virol J Methodology BACKGROUND: Investigating the neutralizing antibody (NAb) titer against HSV-1 is essential for monitoring the immune protection against HSV-1 in susceptible populations, which would facilitate the development of vaccines against herpes infection and improvement of HSV-1 based oncolytic virotherapy. RESULTS: In this study, we have developed a neutralization test based on the enzyme-linked immunospot assay (ELISPOT-NT) to determine the neutralizing antibody titer against HSV-1 in human serum samples. This optimized assay employed a monoclonal antibody specifically recognizing glycoprotein D to detect the HSV-1 infected cells. With this test, the neutralizing antibody titer against HSV-1 could be determined within one day by automated interpretation of the counts of cell spots. We observed good correlation in the results obtained from ELISPOT-NT and plaque reduction neutralization test (PRNT) by testing 22 human serum samples representing different titers. Moreover, 269 human serum samples collected from a wide range of age groups were tested, the average neutralizing antibody titer (log(2)NT(50)) was 8.3 ± 2.8 and the prevalence of NAbs was 83.6 % in this cohort, it also revealed that the average neutralizing antibody titer in different groups increased with the age, and no significant difference in neutralizing antibody titers was observed between males and females. CONCLUSIONS: These results prove that this novel assay would serve as an accurate and simple assay for the assessment of the neutralizing antibody titers against HSV-1 in large cohorts. BioMed Central 2016-03-18 /pmc/articles/PMC4797254/ /pubmed/26987753 http://dx.doi.org/10.1186/s12985-016-0508-4 Text en © Luo et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Luo, Yong Xiong, Dan Li, Huan-Huan Qiu, Sheng-Ping Lin, Chao-Long Chen, Qin Huang, Cheng-Hao Yuan, Quan Zhang, Jun Xia, Ning-Shao Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera |
title | Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera |
title_full | Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera |
title_fullStr | Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera |
title_full_unstemmed | Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera |
title_short | Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera |
title_sort | development of an hsv-1 neutralization test with a glycoprotein d specific antibody for measurement of neutralizing antibody titer in human sera |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797254/ https://www.ncbi.nlm.nih.gov/pubmed/26987753 http://dx.doi.org/10.1186/s12985-016-0508-4 |
work_keys_str_mv | AT luoyong developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT xiongdan developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT lihuanhuan developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT qiushengping developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT linchaolong developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT chenqin developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT huangchenghao developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT yuanquan developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT zhangjun developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera AT xianingshao developmentofanhsv1neutralizationtestwithaglycoproteindspecificantibodyformeasurementofneutralizingantibodytiterinhumansera |